CL2019002600A1 - Conjugado de fármaco-polímero. - Google Patents
Conjugado de fármaco-polímero.Info
- Publication number
- CL2019002600A1 CL2019002600A1 CL2019002600A CL2019002600A CL2019002600A1 CL 2019002600 A1 CL2019002600 A1 CL 2019002600A1 CL 2019002600 A CL2019002600 A CL 2019002600A CL 2019002600 A CL2019002600 A CL 2019002600A CL 2019002600 A1 CL2019002600 A1 CL 2019002600A1
- Authority
- CL
- Chile
- Prior art keywords
- group
- drug
- polymer conjugate
- indicates
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/08—Polyhydrazides; Polytriazoles; Polyaminotriazoles; Polyoxadiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/458,546 US10113033B2 (en) | 2013-03-08 | 2017-03-14 | Polymer conjugate for delivery of a bioactive agent |
| AU2017900888A AU2017900888A0 (en) | 2017-03-14 | Biodegradable drug-polymer conjugate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2019002600A1 true CL2019002600A1 (es) | 2020-04-03 |
Family
ID=63521659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019002600A CL2019002600A1 (es) | 2017-03-14 | 2019-09-12 | Conjugado de fármaco-polímero. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11787906B2 (https=) |
| EP (2) | EP3595670A4 (https=) |
| JP (2) | JP7355649B2 (https=) |
| KR (2) | KR102642432B1 (https=) |
| CN (4) | CN110461336A (https=) |
| AU (2) | AU2018233158B2 (https=) |
| CA (1) | CA3054084A1 (https=) |
| CL (1) | CL2019002600A1 (https=) |
| IL (2) | IL269321B (https=) |
| MX (2) | MX2019010837A (https=) |
| NZ (2) | NZ756626A (https=) |
| SG (2) | SG11201907956UA (https=) |
| WO (2) | WO2018165710A1 (https=) |
| ZA (2) | ZA201905589B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11696955B2 (en) | 2017-03-14 | 2023-07-11 | Polyactiva Pty Ltd | Drug-polymer conjugate |
| MX2019010837A (es) * | 2017-03-14 | 2019-12-19 | Polyactiva Pty Ltd | Conjugado biodegradable de farmaco-polimero. |
| WO2021024041A1 (en) | 2019-08-07 | 2021-02-11 | Ripple Therapeutics Corporation | Controlled release drug dimers |
| CA3154867A1 (en) * | 2019-09-19 | 2021-03-25 | Polyactiva Pty Ltd | Biodegradable drug-polymer conjugate |
| MX2022013665A (es) | 2020-05-01 | 2022-11-30 | Ripple Therapeutics Corp | Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares. |
| WO2024084056A1 (en) * | 2022-10-21 | 2024-04-25 | Etherna Immunotherapies Nv | Ionizable lipids |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1044797B (it) | 1974-10-15 | 1980-04-21 | Ferruti Paolo | Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego |
| JPH03220201A (ja) | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
| JP4419368B2 (ja) | 2002-07-25 | 2010-02-24 | 小野薬品工業株式会社 | プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤 |
| CA2617907A1 (en) | 2005-08-05 | 2007-02-15 | Syntarga B.V. | Triazole-containing releasable linkers and conjugates comprising the same |
| MY155629A (en) | 2008-10-10 | 2015-11-13 | Polyactiva Pty Ltd | Biodegradable polymer-bioactive moiety conjugates |
| SI2340271T1 (sl) | 2008-10-10 | 2019-08-30 | Polyactiva Pty Ltd. | Konjugati polimer-bioaktivnega sredstva |
| US8535655B2 (en) * | 2008-10-10 | 2013-09-17 | Polyactiva Pty Ltd. | Biodegradable polymer—bioactive moiety conjugates |
| US20100104654A1 (en) | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| US20120130045A1 (en) | 2009-06-01 | 2012-05-24 | Ablitech, Inc. | Biomolecule-polymer conjugates and methods of making same |
| FR2961694B1 (fr) | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| WO2012075117A2 (en) | 2010-12-01 | 2012-06-07 | Ablitech, Inc. | Small molecule-polymer conjugates and methods of making same |
| WO2012139164A1 (en) * | 2011-04-12 | 2012-10-18 | Polyactiva Pty Ltd | Polymer conjugated prostaglandin analogues |
| JP2013035802A (ja) | 2011-08-10 | 2013-02-21 | D Western Therapeutics Institute Inc | 緑内障又は高眼圧症の予防又は治療剤 |
| MY190370A (en) * | 2012-06-26 | 2022-04-18 | Polyactiva Pty Ltd | Polymer-nsaid conjugate |
| US10113033B2 (en) | 2013-03-08 | 2018-10-30 | Polyactiva Pty Ltd | Polymer conjugate for delivery of a bioactive agent |
| DK2964224T3 (en) * | 2013-03-08 | 2024-10-14 | Polyactiva Pty Ltd | Polymer conjugate for delivery of a bioactive agent |
| MX2019010837A (es) * | 2017-03-14 | 2019-12-19 | Polyactiva Pty Ltd | Conjugado biodegradable de farmaco-polimero. |
| US11696955B2 (en) | 2017-03-14 | 2023-07-11 | Polyactiva Pty Ltd | Drug-polymer conjugate |
| US11207417B2 (en) | 2017-03-14 | 2021-12-28 | Polyactiva Pty Ltd | Drug-polymer conjugate |
-
2018
- 2018-03-14 MX MX2019010837A patent/MX2019010837A/es unknown
- 2018-03-14 AU AU2018233158A patent/AU2018233158B2/en active Active
- 2018-03-14 EP EP18767240.7A patent/EP3595670A4/en active Pending
- 2018-03-14 JP JP2019551318A patent/JP7355649B2/ja active Active
- 2018-03-14 IL IL269321A patent/IL269321B/en unknown
- 2018-03-14 AU AU2018233159A patent/AU2018233159C1/en active Active
- 2018-03-14 US US16/493,252 patent/US11787906B2/en active Active
- 2018-03-14 SG SG11201907956UA patent/SG11201907956UA/en unknown
- 2018-03-14 SG SG11201907931WA patent/SG11201907931WA/en unknown
- 2018-03-14 EP EP18768053.3A patent/EP3595728A4/en active Pending
- 2018-03-14 JP JP2019551307A patent/JP7204661B2/ja active Active
- 2018-03-14 KR KR1020197027318A patent/KR102642432B1/ko active Active
- 2018-03-14 CN CN201880017971.3A patent/CN110461336A/zh active Pending
- 2018-03-14 NZ NZ756626A patent/NZ756626A/en unknown
- 2018-03-14 MX MX2019010904A patent/MX2019010904A/es unknown
- 2018-03-14 KR KR1020197029230A patent/KR102642433B1/ko active Active
- 2018-03-14 CN CN202511024390.0A patent/CN120919336A/zh active Pending
- 2018-03-14 WO PCT/AU2018/050233 patent/WO2018165710A1/en not_active Ceased
- 2018-03-14 WO PCT/AU2018/050234 patent/WO2018165711A1/en not_active Ceased
- 2018-03-14 IL IL269323A patent/IL269323B/en unknown
- 2018-03-14 CN CN201880029815.9A patent/CN110662561A/zh active Pending
- 2018-03-14 CN CN202511030510.8A patent/CN120919337A/zh active Pending
- 2018-03-14 NZ NZ757356A patent/NZ757356A/en unknown
- 2018-03-14 CA CA3054084A patent/CA3054084A1/en active Pending
-
2019
- 2019-08-23 ZA ZA2019/05589A patent/ZA201905589B/en unknown
- 2019-09-12 CL CL2019002600A patent/CL2019002600A1/es unknown
- 2019-09-17 ZA ZA2019/06133A patent/ZA201906133B/en unknown
-
2023
- 2023-07-26 US US18/226,713 patent/US12503553B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019002600A1 (es) | Conjugado de fármaco-polímero. | |
| UY31472A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
| CL2016001514A1 (es) | Conjugado de anticuerpo-farmaco que posee un resto quimico no peptidico, que puede ser escindido por la catepsina b; uso para la fabricacion de un medicamento util y conjugacion farmaceutica. | |
| EA201791359A1 (ru) | Конъюгаты, связывающие белок-лекарственное средство, содержащие производные антрациклина | |
| UY33541A (es) | N-((6-amino-piridin-3-il)-metil)-heteroaril-carboxamidas | |
| CO2020012593A2 (es) | Derivados de oxadiazolina | |
| MX2015016071A (es) | Auto-calendario. | |
| MA38686A1 (fr) | Anticorps anti-acide téichoïque de la paroi cellulaire et conjugués associés | |
| BR112015022763A2 (pt) | sensores de oxigênio | |
| EA201591665A1 (ru) | Оральные составы деферазирокса | |
| AR110125A1 (es) | Compuestos poliméricos que liberan sulfuro de hidrógeno | |
| CY1114166T1 (el) | Ενωση ακυλοθειουριας ή αλας αυτης, και χρηση της ενωσης ή του αλατος | |
| CR20120261A (es) | Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica | |
| MA44550B1 (fr) | Anticorps anti-acide téichoique de la paroi cellulaire et conjugués associés | |
| CL2023003124A1 (es) | Anticuerpos anti-tslp modificados | |
| ECSP11011224A (es) | Derivados de tiadiazoles y oxadiazoles, su preparaciòn y su aplicaciòn en terapia | |
| UY38761A (es) | Oxadiazoles fungicidas | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| PY18111999A (es) | Hidroxiisoxazolinas y derivados de estos | |
| UA116654C2 (uk) | Похідні пурину як агоністи канабіноїдного рецептора св2 | |
| MX2015015906A (es) | Mejoras en o con relacion a compuestos organicos. | |
| ECSP16096831A (es) | Derivados de naftiridinadiona | |
| BR112019001201A2 (pt) | sacola hidrodegradável | |
| CL2021001425A1 (es) | Composición acuosa estable que comprende oligosacáridos | |
| CL2019002025A1 (es) | Derivados de pirrolotriazina como inhibidor de cinasas. |